Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity-Reference-Cited by-同舟云学术

Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity

Published:2021-03 Issue:3 Volume:54 Page:557-570.e5
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Hoagland Daisy A.,Møller Rasmus,Uhl Skyler A.,Oishi Kohei,Frere Justin,Golynker Ilona,Horiuchi Shu,Panis Maryline,Blanco-Melo Daniel,Sachs David,Arkun Knarik,Lim Jean K.,tenOever Benjamin R.

Funder

Defense Advanced Research Projects Agency

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference75 articles.

1. A serological assay to detect SARS-CoV-2 seroconversion in humans;Amanat;Nat. Med.,2020

2. CRISPR provides acquired resistance against viruses in prokaryotes;Barrangou;Science,2007

3. Autoantibodies against type I IFNs in patients with life-threatening COVID-19;Bastard;Science,2020

4. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19;Blanco-Melo;Cell,2020

5. STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters;Boudewijns;Nat. Commun.,2020

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-MDA5 autoantibodies predict clinical dynamics of dermatomyositis following SARS-CoV-2 mRNA vaccination: a retrospective statistical analysis of case reports;Rheumatology International;2024-08-27

2. Innate immune signatures in the nasopharynx after SARS-CoV-2 infection and links with the clinical outcome of COVID-19 in Omicron-dominant period;Cellular and Molecular Life Sciences;2024-08-22

3. Pandemic-associated pernio harbors footprints of an abortive SARS-CoV-2 infection;iScience;2024-08

4. An intranasal nanoparticle STING agonist protects against respiratory viruses in animal models;Nature Communications;2024-07-18

5. Innate immune signatures in the nasopharynx after SARS-CoV-2 Infection and links with the clinical outcome of COVID-19 in Omicron-dominant period;2024-07-18